Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: ValuEngine, Inc.
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abiomed Inc maintains FY 2014 revenue outlook

Thursday, 30 Jan 2014 07:03am EST 

Abiomed Inc:Says it is maintaining its FY 2014 guidance.Sees FY 2014 total revenues to be in the range of $180 mln to $185 mln with worldwide Impella revenues increasing about 20 pct.GY 2014 revenue of $183 mln - Thomson Reuters I/B/E/S. 

Company Quote

0.29 +1.21%
15 Apr 2014